Zillow Inc (NASDAQ:Z) is now challenging the upper end of a 1-month range at the highs of the year. Zillow Inc. (NASDAQ:Z) stock opened today at $106.75 and is currently trading at $111.12. The stock showed a positive weekly performance of 9.47%.
AT&T agreed Sunday to buy DirecTV (NASDAQ:DTV) for $48.5 billion in yet another mammoth deal in the pay-TV space this year that would immediately boost the telecom giant’s customer base at a time of confounding industry challenges. DIRECTV (NASDAQ:DTV) stock opened at $84.88, in current trading session and currently is at $84.38, by losing -2.09%. The 52 week range of $57.05 – $89.46. Company’s market capitalization is 42.51 billion.
PepsiCo Inc (NYSE:PEP), which has been hit with declining demand for its packaged carbonated drinks and is looking for alternative revenue streams, may also be interested in a deal with SodaStream. It has already joined hands with the Europe-based Bevyz to launch its flavored sachets compatible with Bevyz’s own multi-drink beverage machine, due this month. PepsiCo, Inc. (NYSE:PEP) stock is currently trading at $85.61. The EPS of the stock is 4.42. Company’s market capitalization is 129.79 billion.
The U.K.’s AstraZeneca plc (ADR) (NYSE:AZN) on Monday took the bold step of rejecting a thrice-sweetened £69.4 billion ($116.8 billion) takeover proposal from Pfizer Inc., which had on Sunday ruled out hostile action and declared its latest offer final. AstraZeneca plc (ADR) (NYSE:AZN) stock opened the session at $71.35, and now is at $72.62. The 52 week range of the AstraZeneca plc (ADR) (NYSE:AZN) stock remained $46.87 – $82.68 and the day range was $70.92 – $72.85.
MannKind Corporation (NASDAQ:MNKD) In the U.S. alone, roughly 1 of 12 people are managing diabetes. China has approximately 100 million diabetic patients as of 2012 statistics. Total global insulin sales have grown an average of $4 billion a year between 2011 and 2012 ($16.8B in 2011 and $20.8B in 2012). However, in 2013, sharp price increases sent the total market up to $35 billion. By 2018, total insulin sales are expected to increase 66% to reach more than $58 billion due to continued increase in price and patients. MannKind Corporation (NASDAQ:MNKD) stock opened today at $7.02 and is currently trading at $7.41. The stock showed a positive weekly performance of 12.86%.
Leave a Reply